Clinical trials recruiting in Baloteşti, Romania
5
Recruiting trials
7
Conditions
Phase breakdown
Phase 3 5
Conditions recruiting in Baloteşti, Romania
| Condition | Trials |
|---|---|
| Heart Failure | 2 |
| Atherosclerosis Cardiovascular Disease | 1 |
| Atrial Fibrillation (AF) | 1 |
| Atrial fibrillation | 1 |
| Chronic Kidney Disease | 1 |
| Lung cancer | 1 |
| Non-Small Cell Lung Cancer (NSCLC) | 1 |
Recruiting trials in Baloteşti, Romania
- A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)
- A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
- A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
- A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
- Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
Common questions
How many clinical trials are recruiting in Baloteşti, Romania?
5 recruiting trials have at least one study site in Baloteşti, Romania.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.